| Literature DB >> 35263568 |
Carlene L Zindl1, Steven J Witte2, Vincent A Laufer2, Min Gao3, Zongliang Yue3, Karen M Janowski4, Baiyi Cai5, Blake F Frey5, Daniel J Silberger5, Stacey N Harbour5, Jeffrey R Singer5, Henrietta Turner5, Frances E Lund6, Bruce A Vallance7, Alexander F Rosenberg8, Trenton R Schoeb4, Jake Y Chen3, Robin D Hatton5, Casey T Weaver9.
Abstract
Interleukin (IL)-22 is central to immune defense at barrier sites. We examined the contributions of innate lymphoid cell (ILC) and T cell-derived IL-22 during Citrobacter rodentium (C.r) infection using mice that both report Il22 expression and allow lineage-specific deletion. ILC-derived IL-22 activated STAT3 in C.r-colonized surface intestinal epithelial cells (IECs) but only temporally restrained bacterial growth. T cell-derived IL-22 induced a more robust and extensive activation of STAT3 in IECs, including IECs lining colonic crypts, and T cell-specific deficiency of IL-22 led to pathogen invasion of the crypts and increased mortality. This reflected a requirement for T cell-derived IL-22 for the expression of a host-protective transcriptomic program that included AMPs, neutrophil-recruiting chemokines, and mucin-related molecules, and it restricted IFNγ-induced proinflammatory genes. Our findings demonstrate spatiotemporal differences in the production and action of IL-22 by ILCs and T cells during infection and reveal an indispensable role for IL-22-producing T cells in the protection of the intestinal crypts.Entities:
Keywords: AMPs; CD4 T cells; Citrobacter rodentium; IFNγ; IL-22; TNF; chemokines; colonic crypt IECs; colonic surface IECs; innate cells; mucins
Mesh:
Substances:
Year: 2022 PMID: 35263568 PMCID: PMC9126440 DOI: 10.1016/j.immuni.2022.02.003
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 43.474